Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Vanadate supplements and 1,2-dimethylhydrazine induced colon cancer in mice: Increased thymidine incorporation without enhanced carcinogenesis

Abstract

Because vanadate ion is a potent mitogen and accumulates in the gut of rodents fed vanadate supplements, effects of ammonium metavanadate in drinking water (10 ppm or 20 ppm) were studied on the development of large bowel neoplasms in mice treated with 1,2-dimethylhydrazine (DMH) (20 mg kg-1 weekly for 20 weeks). In the colon at 30 weeks DMH treatment caused a 14% increase in RNA content, an 18% increase in DNA content, and 33% deeper crypts. Vanadate at either 10 ppm or 20 ppm decreased RNA content by approximately 11%. Although vanadate increased thymidine incorporation 210% to 550% compared with controls, it had no influence on the attack rate, incidence, or histological type of tumours induced by DMH.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kingsnorth, A., LaMuraglia, G., Ross, J. et al. Vanadate supplements and 1,2-dimethylhydrazine induced colon cancer in mice: Increased thymidine incorporation without enhanced carcinogenesis. Br J Cancer 53, 683–686 (1986). https://doi.org/10.1038/bjc.1986.112

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/bjc.1986.112

This article is cited by

Search

Quick links